Edwards Lifesciences Corp
EW
Company Profile
Business description
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Contact
One Edwards Way
IrvineCA92614
USAT: +1 949 250-2500
E: investor_relations@edwards.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
15,800
Stocks News & Analysis
personal-finance
US stock market outlook: tariffs are 2025's wild card
Macrodynamic tailwinds persist, but stocks are already priced to perfection. Will tariffs derail the market in 2025?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,586.70 | 15.30 | 0.18% |
| CAC 40 | 7,720.46 | 143.98 | -1.83% |
| DAX 40 | 23,636.13 | 363.04 | -1.51% |
| Dow JONES (US) | 41,570.10 | 288.99 | -0.69% |
| FTSE 100 | 8,704.17 | 35.09 | -0.40% |
| HKSE | 23,601.26 | 56.95 | 0.24% |
| NASDAQ | 18,718.04 | 207.70 | -1.10% |
| Nikkei 225 | 37,160.47 | 174.60 | 0.47% |
| NZX 50 Index | 12,596.50 | 65.75 | -0.52% |
| S&P 500 | 5,792.07 | 49.94 | -0.85% |
| S&P/ASX 200 | 8,360.90 | 12.20 | 0.15% |
| SSE Composite Index | 3,348.37 | 31.82 | -0.94% |